Download PDF
Semin intervent Radiol 2022; 39(05): 523-525
DOI: 10.1055/s-0042-1758111
Review Article

COVID-Related Thrombosis and Overall Implications Related to Percutaneous Interventions

Robert A. Lookstein
1   Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

The SARS-COV-2/ COVID-19 pandemic created unique, once in a lifetime challenges for healthcare workers across the globe. One of the challenges specific to interventional radiology was the increased incidence of vascular thrombosis leading to urgent and emergent clinical patient management issues. Limited healthcare resources and complex clinical presentations required innovative solutions, and workflows to manage the increased burden on the healthcare providers.

Keywords

thrombosis - COVID-19 - peripheral vascular disease


Publication History

Article published online:
20 December 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Driggin E, Madhavan MV, Bikdeli B. et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020; 75 (18) 2352-2371
    CrossrefPubMedGoogle Scholar
  • 2 Gerhard-Herman MD, Gornik HL, Barrett C. et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol 2017; 69 (11) e71-e126
    CrossrefPubMedGoogle Scholar
  • 3 Patel P, Yu Y, Zia S, Padberg F, Curi M, Huang J. Systemic thrombolysis as initial treatment of COVID-19 associated acute aortoiliac and lower extremity arterial thrombosis. Ann Vasc Surg 2021; 70: 297-301
    CrossrefPubMedGoogle Scholar
  • 4 Information for Healthcare Professionals about Coronavirus (COVID-19). Updated December 13, 2020. Accessed October 5, 2022 at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html
    PubMedGoogle Scholar
  • 5 Poissy J, Goutay J, Caplan M. et al; Lille ICU Haemostasis COVID-19 Group. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation 2020; 142 (02) 184-186
    CrossrefPubMedGoogle Scholar
  • 6 Klok FA, Kruip MJHA, van der Meer NJM. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 2020; 191: 148-150
    CrossrefPubMedGoogle Scholar
  • 7 Goyal P, Choi JJ, Pinheiro LC. et al. Clinical characteristics of COVID-19 in New York City. N Engl J Med 2020; 382 (24) 2372-2374
    CrossrefPubMedGoogle Scholar
  • 8 Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020; 18 (06) 1421-1424
    CrossrefPubMedGoogle Scholar
  • 9 Middeldorp S, Coppens M, van Haaps TF. et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost 2020; 18 (08) 1995-2002
    CrossrefPubMedGoogle Scholar
  • 10 Wang T, Chen R, Liu C. et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol 2020; 7 (05) e362-e363
    CrossrefPubMedGoogle Scholar
  • 11 Moores LK, Tritschler T, Brosnahan S. et al. Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19. CHEST Guideline and Expert Panel Report Chest 2020; 158 (03) 1143-1163
    PubMedGoogle Scholar
  • 12 Giri J, Sista AK, Weinberg I. et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American Heart Association. Circulation 2019; 140 (20) e774-e801
    CrossrefPubMedGoogle Scholar